Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

OBJECTIVE: Poor outcomes have been reported in patients with type 2 diabetes and coronavirus disease 2019 (COVID-19); thus, it is mandatory to explore novel therapeutic approaches for this population. RESEARCH DESIGN AND METHODS: In a multicenter, case-control, retrospective, observational study, si...

Descripción completa

Detalles Bibliográficos
Autores principales: Solerte, Sebastiano Bruno, D’Addio, Francesca, Trevisan, Roberto, Lovati, Elisabetta, Rossi, Antonio, Pastore, Ida, Dell’Acqua, Marco, Ippolito, Elio, Scaranna, Cristiana, Bellante, Rosalia, Galliani, Silvia, Dodesini, Alessandro Roberto, Lepore, Giuseppe, Geni, Francesca, Fiorina, Roberta Maria, Catena, Emanuele, Corsico, Angelo, Colombo, Riccardo, Mirani, Marco, De Riva, Carlo, Oleandri, Salvatore Endrio, Abdi, Reza, Bonventre, Joseph V., Rusconi, Stefano, Folli, Franco, Di Sabatino, Antonio, Zuccotti, Gianvincenzo, Galli, Massimo, Fiorina, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770266/
https://www.ncbi.nlm.nih.gov/pubmed/32994187
http://dx.doi.org/10.2337/dc20-1521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770266/
https://www.ncbi.nlm.nih.gov/pubmed/32994187
http://dx.doi.org/10.2337/dc20-1521

Ejemplares similares